Explore breakthrough studies, CRISPR applications, and transformative discoveries in gene editing technology
Discover how FTY720, an MS drug, could revolutionize cardiac care by reversing existing cardiac hypertrophy and fibrosis through targeting NFAT signaling and periostin.